|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 38/12 |
| (11) | Number of the document | 3054924 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14780863.8 |
| Date of filing the European patent application | 2014-10-06 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/071302 |
| Date | 2014-10-06 |
| (87) | Number | WO 2015/052115 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 13187612 | 2013-10-07 | EP | |
| 14155993 | 2014-02-20 | EP | |
| 14162110 | 2014-03-27 | EP |
| (72) |
CUBEL SUŃÉ, N ria, ES
|
| (73) |
Centrient Pharmaceuticals Netherlands B.V.,
Alexander Fleminglaan 1, 2613 AX Delft,
NL
Galenicum Health S.L.U., Avinguda de Cornellą 144, 7th floor, 08950 Esplugues de Llobregat, ES |
| (54) | STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |
| STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |